{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:57:13Z","timestamp":1794272233950,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04275-2","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:51:44Z","timestamp":1776055904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic\u2013airway eosinophil discordance and sputum mediator profiling in severe asthma treated with biologics: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Moe","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakana","family":"Uji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Koda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichiro","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Sofuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Naramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"4275_CR1","unstructured":"Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2025, Available at: http:\/\/www.ginasthma.org\/. Accessed 15 Sep 2025."},{"key":"4275_CR2","doi-asserted-by":"crossref","unstructured":"Busse WW, Kraft M, Rabe KF, Deniz Y, Rowe PJ, Ruddy M, Castro M: Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J. 2021;58(2)2003393.","DOI":"10.1183\/13993003.03393-2020"},{"issue":"4","key":"4275_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","volume":"3","author":"DA Korevaar","year":"2015","unstructured":"Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(4):290\u2013300.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"4275_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.resinv.2020.05.006","volume":"59","author":"K Matsunaga","year":"2021","unstructured":"Matsunaga K, Kuwahira I, Hanaoka M, Saito J, Tsuburai T, Fukunaga K, Matsumoto H, Sugiura H, Ichinose M. Japanese Respiratory Society Assembly on Pulmonary P: An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice. Respir Investig. 2021;59(1):34\u201352.","journal-title":"Respir Investig."},{"issue":"7","key":"4275_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2169\/internalmedicine.51.6834","volume":"51","author":"Z Liang","year":"2012","unstructured":"Liang Z, Zhao H, Lv Y, Li R, Dong H, Liu L, et al. Moderate accuracy of peripheral eosinophil count for predicting eosinophilic phenotype in steroid-naive non-atopic adult asthmatics. Intern Med. 2012;51(7):717\u201322.","journal-title":"Intern Med"},{"key":"4275_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-13-11","volume":"13","author":"FN Schleich","year":"2013","unstructured":"Schleich FN, Manise M, Sele J, Henket M, Seidel L, Louis R. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med. 2013;13:11.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"4275_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","volume":"70","author":"AH Wagener","year":"2015","unstructured":"Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115\u201320.","journal-title":"Thorax"},{"key":"4275_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0248-7","volume":"14","author":"J Gao","year":"2018","unstructured":"Gao J, Wu F. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy Asthma Clin Immunol. 2018;14:21.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"4275_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/JAA.S389402","volume":"16","author":"A Crespo-Lessmann","year":"2023","unstructured":"Crespo-Lessmann A, Curto E, Mateus Medina EF, Palones E, Belda Soler A, Sanchez Maza S, et al. Characteristics of induced-sputum inflammatory phenotypes in adults with asthma: predictors of bronchial eosinophilia. J Asthma Allergy. 2023;16:95\u2013103.","journal-title":"J Asthma Allergy"},{"issue":"4","key":"4275_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.18176\/jiaci.0647","volume":"31","author":"ML Caballero","year":"2021","unstructured":"Caballero ML, Dominguez-Ortega J, Nin-Valencia AR, Sanchez-Ocando H, Barranco P. Eosinophil count could be more sensitive in induced sputum than in peripheral blood for phenotyping of patients with severe eosinophilic asthma. J Investig Allergol Clin Immunol. 2021;31(4):360\u20131.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"4275_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"8","key":"4275_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","volume":"171","author":"American Thoracic S","year":"2005","unstructured":"American Thoracic S, European Respiratory S. ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4275_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1164\/ajrccm.156.1.9610114","volume":"156","author":"HH Wong","year":"1997","unstructured":"Wong HH, Fahy JV. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med. 1997;156(1):299\u2013303.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"4275_CR14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1183\/09031936.97.10081809","volume":"10","author":"MC Ronchi","year":"1997","unstructured":"Ronchi MC, Piragino C, Rosi E, Stendardi L, Tanini A, Galli G, et al. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Respir J. 1997;10(8):1809\u201313.","journal-title":"Eur Respir J"},{"issue":"2","key":"4275_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/thx.53.2.91","volume":"53","author":"A Jatakanon","year":"1998","unstructured":"Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53(2):91\u20135.","journal-title":"Thorax"},{"key":"4275_CR16","doi-asserted-by":"crossref","unstructured":"Virchow JC, Jr., Holscher U, Virchow C, Sr. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis. 1992;146(3):604\u2013606.","DOI":"10.1164\/ajrccm\/146.3.604"},{"issue":"3","key":"4275_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1172\/JCI95693","volume":"128","author":"EM Dunican","year":"2018","unstructured":"Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest. 2018;128(3):997\u20131009.","journal-title":"J Clin Invest"},{"issue":"8","key":"4275_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1159\/000530392","volume":"184","author":"N Sakai","year":"2023","unstructured":"Sakai N, Koya T, Murai Y, Tsubokawa F, Tanaka K, Naramoto S, et al. Effect of benralizumab on mucus plugs in severe eosinophilic asthma. Int Arch Allergy Immunol. 2023;184(8):783\u201391.","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"4275_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/02770903.2020.1786111","volume":"58","author":"MM Refaat","year":"2021","unstructured":"Refaat MM, El Sayed E, Abd El-Fattah W, Elbanna AH, Sayed HME. Relationship between sputum periostin level and inflammatory asthma phenotypes in Egyptian patients. J Asthma. 2021;58(10):1285\u201391.","journal-title":"J Asthma"},{"issue":"5","key":"4275_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/resp.14491","volume":"28","author":"T Al-Shaikhly","year":"2023","unstructured":"Al-Shaikhly T, Murphy RC, Lai Y, Frevert CW, Debley JS, Ziegler SF, et al. Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma. Respirology. 2023;28(5):491\u20134.","journal-title":"Respirology"},{"issue":"4","key":"4275_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0091-6749(95)70128-1","volume":"95","author":"JV Fahy","year":"1995","unstructured":"Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995;95(4):843\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"4275_CR22","doi-asserted-by":"crossref","unstructured":"Gomez JL, Yan X, Holm CT, Grant N, Liu Q, Cohn L, Nezgovorova V, Meyers DA, Bleecker ER, Crisafi GM et al: Characterisation of asthma subgroups associated with circulating YKL-40 levels. Eur Respir J. 2017;50(4)1700800.","DOI":"10.1183\/13993003.00800-2017"},{"issue":"6","key":"4275_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1159\/000330840","volume":"83","author":"K Otsuka","year":"2012","unstructured":"Otsuka K, Matsumoto H, Niimi A, Muro S, Ito I, Takeda T, et al. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration. 2012;83(6):507\u201319.","journal-title":"Respiration"},{"issue":"6","key":"4275_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/thx.2010.136523","volume":"66","author":"JB Morjaria","year":"2011","unstructured":"Morjaria JB, Babu KS, Vijayanand P, Chauhan AJ, Davies DE, Holgate ST. Sputum IL-6 concentrations in severe asthma and its relationship with FEV1. Thorax. 2011;66(6):537.","journal-title":"Thorax"},{"issue":"1","key":"4275_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1183\/09031936.00201813","volume":"44","author":"FN Schleich","year":"2014","unstructured":"Schleich FN, Chevremont A, Paulus V, Henket M, Manise M, Seidel L, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J. 2014;44(1):97\u2013108.","journal-title":"Eur Respir J"},{"issue":"16","key":"4275_CR26","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.2174\/1389450119666180212120012","volume":"19","author":"K Kostikas","year":"2018","unstructured":"Kostikas K, Brindicci C, Patalano F. Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD. Curr Drug Targets. 2018;19(16):1882\u201396.","journal-title":"Curr Drug Targets"},{"issue":"5","key":"4275_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1164\/rccm.202201-0129OC","volume":"206","author":"PJ McDowell","year":"2022","unstructured":"McDowell PJ, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker S, et al. Exacerbation profile and risk factors in a type-2-low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes. Am J Respir Crit Care Med. 2022;206(5):545\u201353.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4275_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54\u201361.","journal-title":"Respirology"},{"issue":"2","key":"4275_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jaci.2018.05.026","volume":"143","author":"Z Jevnikar","year":"2019","unstructured":"Jevnikar Z, Ostling J, Ax E, Calven J, Thorn K, Israelsson E, Oberg L, Singhania A, Lau LCK, Wilson SJ, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2019;143(2):577\u201390.","journal-title":"J Allergy Clin Immunol."},{"key":"4275_CR30","doi-asserted-by":"crossref","unstructured":"Pavord ID, Buhl R, Kraft M, Prazma CM, Price RG, Howarth PH, Yancey SW: Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab. ERJ Open Res. 2022;8(2) :00560\u20132021.","DOI":"10.1183\/23120541.00560-2021"},{"issue":"12","key":"4275_CR31","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1164\/rccm.202308-1413LE","volume":"208","author":"M Mukherjee","year":"2023","unstructured":"Mukherjee M, Huang C, Venegas-Garrido C, Zhang K, Bhalla A, Ju X, et al. Benralizumab normalizes sputum eosinophilia in severe asthma uncontrolled by anti-IL-5 antibodies: a single-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 2023;208(12):1330\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"4275_CR32","doi-asserted-by":"crossref","unstructured":"Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S et al: Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2023;11(4):1213\u20131220 e1212.","DOI":"10.1016\/j.jaip.2022.11.043"},{"issue":"4","key":"4275_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2025.05.031","volume":"156","author":"PJ McDowell","year":"2025","unstructured":"McDowell PJ, Azim A, Busby J, Diver S, Yang F, Borg C, et al. Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma. J Allergy Clin Immunol. 2025;156(4):911\u201322.","journal-title":"J Allergy Clin Immunol"},{"key":"4275_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108151","volume":"243","author":"C Moermans","year":"2025","unstructured":"Moermans C, Decerf N, Javaux N, Onssels A, Bricmont N, Bonhiver R, et al. High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor. Respir Med. 2025;243:108151.","journal-title":"Respir Med"},{"issue":"9","key":"4275_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.7150\/ijbs.4874","volume":"8","author":"M Rincon","year":"2012","unstructured":"Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 2012;8(9):1281\u201390.","journal-title":"Int J Biol Sci"},{"key":"4275_CR36","doi-asserted-by":"crossref","unstructured":"Li X, Hastie AT, Peters MC, Hawkins GA, Phipatanakul W, Li H, Moore WC, Busse WW, Castro M, Erzurum SC et al: Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma. J Allergy Clin Immunol. 2020;145(1):430\u2013433.","DOI":"10.1016\/j.jaci.2019.08.031"},{"issue":"9","key":"4275_CR37","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1164\/rccm.202306-1102LE","volume":"208","author":"S Svenningsen","year":"2023","unstructured":"Svenningsen S, Kjarsgaard M, Haider E, Venegas C, Konyer N, Friedlander Y, et al. Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2023;208(9):995\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4275_CR38","doi-asserted-by":"crossref","unstructured":"Murai Y, Koya T, Koda H, Uji W, Tanaka M, Endo M, Oshima K, Matsuda T, Ueno H, Aoki A et al: Dupilumab efficacy in relation to changes in club cell secretory protein 16. Ann Allergy Asthma Immunol. 2025;134(5):556\u2013562 e552.","DOI":"10.1016\/j.anai.2025.02.019"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04275-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:24:18Z","timestamp":1779243858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04275-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4275"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04275-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8265219\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki and was approved by the Niigata University Ethics Committee (No. 2524). In accordance with national\/institutional policies, individual written informed consent was waived; an opt-out notice describing the study purpose and data handling was posted on the university website and on-site bulletin boards. Patients who opted out were excluded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}